Our Mission
Fearlessly pioneering novel therapies to make meaningful impact and provide hope for patients with fibrotic diseases.
David Lagares, PhD ![LinkedIn for David Lagares, PhD](https://www.mediartx.com/wp-content/themes/mediar/template-parts/blocks/team-member/images/social-linkedin-in-lt-blue.svg)
Assistant Professor of Medicine
Division of Pulmonary & Critical Care Medicine
Massachusetts General Hospital
Harvard Medical School
Bryan Fuchs, PhD ![LinkedIn for Bryan Fuchs, PhD](https://www.mediartx.com/wp-content/themes/mediar/template-parts/blocks/team-member/images/social-linkedin-in-lt-blue.svg)
Vice President, Research Therapeutic Area Head Gastroenterology
Ferring Pharma
Michael Choi, MD ![LinkedIn for Michael Choi, MD](https://www.mediartx.com/wp-content/themes/mediar/template-parts/blocks/team-member/images/social-linkedin-in-lt-blue.svg)
Assistant Professor of Medicine
Department of Gastroenterology
Massachusetts General Hospital
Harvard Medical School
Shelia Violette, PhD ![LinkedIn for Shelia Violette, PhD](https://www.mediartx.com/wp-content/themes/mediar/template-parts/blocks/team-member/images/social-linkedin-in-lt-blue.svg)
Co-founder, Chief Scientific Officer,
and President of Research
Q32 Bio
Thomas Wynn, PhD ![LinkedIn for Thomas Wynn, PhD](https://www.mediartx.com/wp-content/themes/mediar/template-parts/blocks/team-member/images/social-linkedin-in-lt-blue.svg)
Vice President, Inflammation and Immunology
Pfizer